Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
479 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06562166 | Online Adaptive Radiotherapy for Cervical Cancer | recruiting | Phase 2 | 124 | Peking Union Medical College HospitalOTHER | 1 | Jan 8, 2026 | clinicaltrials |
| NCT06375473 | Treatment of Irinotecan Hydrochloride Liposome Injection II in China: a Real World Study of Pancreatic Cancer Patients(MA-PC-RWS-011) | recruiting | — | 3,000 | Peking Union Medical College HospitalOTHER | 1 | Jan 6, 2026 |
| clinicaltrials |
| NCT07317414 | β-alanine in the Treatment of Advanced Hepatocellular Carcinoma | recruiting | Phase 2 | 158 | Peking Union Medical College HospitalOTHER | 1 | Jan 5, 2026 | clinicaltrials |
| NCT06649682 | 68Ga-NYM096/177Lu-NYM096 in Metastatic ccRCC(NYCRRLT) | suspended | Phase 1 | 20 | Peking Union Medical College HospitalOTHER | 1 | Dec 31, 2025 | clinicaltrials |
| NCT07310186 | Treatment and Outcomes of DLBCL After Progression on Polatuzumab Vedotin-based Combination Therapy | not yet recruiting | — | 200 | Peking Union Medical College HospitalOTHER | 0 | Dec 30, 2025 | clinicaltrials |
| NCT07298707 | Cervical Cytology DNA Methylation for Endometrial Lesion Screening and Follow-up(EndoMethy-V) | not yet recruiting | — | 3,500 | Peking Union Medical College HospitalOTHER | 0 | Dec 23, 2025 | clinicaltrials |
| NCT07288931 | Al18F-NOTA-LM3 PET/CT in Patients With Pheochromocytoma and Paraganglioma | recruiting | N/A | 40 | Peking Union Medical College HospitalOTHER | 1 | Dec 17, 2025 | clinicaltrials |
| NCT07282262 | An Exploratory Study on the Use of Ivosidenib for the Precise Treatment of Advanced Biliary Tract Malignancies With IDH1 Mutations in the Later Line of Therapy. | recruiting | Phase 2 | 300 | Peking Union Medical College HospitalOTHER | 1 | Dec 15, 2025 | clinicaltrials |
| NCT06230471 | Pembrolizumab With or Without Lenvatinib or Chemotherapy in First-Line Treatment of Advanced Biliary Tract Cancer | recruiting | Phase 2 | 60 | Peking Union Medical College HospitalOTHER | 1 | Dec 9, 2025 | clinicaltrials |
| NCT07267078 | Tuvonralimab and Iparomlimab Based Regimens for the Neoadjuvant Treatment of Biliary Tract Cancer | recruiting | Phase 2 | 45 | Peking Union Medical College HospitalOTHER | 1 | Dec 5, 2025 | clinicaltrials |
| NCT06545721 | Weight Cycling on Hyperandrogenemia and Insulin Resistance in Polycystic Ovary Syndrome(WHIP) | recruiting | N/A | 425 | Peking Union Medical College HospitalOTHER | 1 | Dec 3, 2025 | clinicaltrials |
| NCT05751018 | Phase II Clinical Study of Pyrotinib in First-line Treatment of Primary HER2-amplified/Mutated Advanced Non-small Cell Lung Cancer | recruiting | Phase 2 | 18 | Peking Union Medical College HospitalOTHER | 1 | Dec 2, 2025 | clinicaltrials |
| NCT07157969 | ICIs and Anti-VEGF Antibody/TKIs With or Without Interventional Therapy for Advanced HCC | recruiting | Phase 2 | 300 | Peking Union Medical College HospitalOTHER | 1 | Dec 1, 2025 | clinicaltrials |
| NCT07254104 | Clinical Evaluation of [68Ga]Ga-NOTA-RF PET Imaging Targeting RFVT3 in Patients With Pituitary Tumors | enrolling by invitation | Early Phase 1 | 30 | Peking Union Medical College HospitalOTHER | 1 | Nov 28, 2025 | clinicaltrials |
| NCT05603559 | 177Lu-P17-087/177Lu-P17-088 in Patients With Metastatic Castration-resistant Prostate Cancer | recruiting | Early Phase 1 | 30 | Peking Union Medical College HospitalOTHER | 1 | Oct 3, 2025 | clinicaltrials |
| NCT05324332 | 68Ga-P16-093 and 68Ga-PSMA-11 PET/CT Imaging in the Same Group of Primary Prostate Cancer Patients | recruiting | N/A | 50 | Peking Union Medical College HospitalOTHER | 1 | Sep 22, 2025 | clinicaltrials |
| NCT07173946 | Prospective Observational Study on ES-SCLC | not yet recruiting | — | 96 | Peking Union Medical College HospitalOTHER | 0 | Sep 15, 2025 | clinicaltrials |
| NCT07161921 | Gut Microbiota and Metabolite Signatures Associated With Lymph Node Metastasis in Pancreatic Cancer | completed | — | 55 | Peking Union Medical College HospitalOTHER | 1 | Sep 9, 2025 | clinicaltrials |
| NCT07159191 | Envafolimab Combined With Axitinib as First-Line Treatment for Patients With Advanced Renal Cell Carcinoma | not yet recruiting | Phase 2 | 30 | Peking Union Medical College HospitalOTHER | 0 | Sep 8, 2025 | clinicaltrials |
| NCT07159217 | Disitamab Vedotin Plus Lenvatinib and PD-1 Inhibitors for Treating HER2-positive Advanced Biliary Tract Cancer | not yet recruiting | Phase 2 | 65 | Peking Union Medical College HospitalOTHER | 1 | Sep 8, 2025 | clinicaltrials |
| NCT07161167 | Changes in Body Composition of Patients With Obesity Related Tumors and Their Impact on Clinical Outcomes: a Multicenter Prospective Cohort Study | not yet recruiting | — | 6,743 | Peking Union Medical College HospitalOTHER | 1 | Sep 8, 2025 | clinicaltrials |
| NCT06196164 | A RCT of Low MBO Drainage Strategies | active not recruiting | N/A | 40 | Peking Union Medical College HospitalOTHER | 1 | Sep 5, 2025 | clinicaltrials |
| NCT07144748 | 68Ga-NYM096 PET/CT in Various Kinds of Cancer(NYCRVT) | recruiting | N/A | 120 | Peking Union Medical College HospitalOTHER | 1 | Sep 5, 2025 | clinicaltrials |
| NCT07153952 | RT for Adenocarcinoma/Adenosquamous Carcinoma | active not recruiting | Phase 1 / Phase 2 | 60 | Peking Union Medical College HospitalOTHER | 1 | Sep 4, 2025 | clinicaltrials |
| NCT07149623 | Metastatic Lymph Node Distribution in the Ileum Mesentery of Cecal and Proximal Ascending Colon Cancer | not yet recruiting | — | 406 | Peking Union Medical College HospitalOTHER | 0 | Sep 2, 2025 | clinicaltrials |
| NCT07149636 | Health Belief Model-Based Survey on Breast Self-Examination Awareness and Practice Among Community-Dwelling Middle-Aged and Older Women(HBM-BSE) | active not recruiting | — | 3,000 | Peking Union Medical College HospitalOTHER | 1 | Sep 2, 2025 | clinicaltrials |
| NCT07147374 | Robotic Versus Open Surgery Following Neoadjuvant Therapy in Pancreatic Cancer: Evaluation of Safety and Oncologic Outcomes | completed | — | 56 | Peking Union Medical College HospitalOTHER | 1 | Aug 29, 2025 | clinicaltrials |
| NCT06861543 | The Purpose of This Study is to Evaluate the Safety, Tolerability and Efficacy of TMT101 Injection Monotherapy in Patients With Advanced Pancreatic Cancer or Non-small Cell Lung Cancer(NSCLC)(TMT101-01) | recruiting | Phase 1 | 18 | Peking Union Medical College HospitalOTHER | 1 | Aug 11, 2025 | clinicaltrials |
| NCT07114666 | XH001 (New Antigen Tumor Vaccine) Combined With Chemotherapy as Adjuvant Therapy in Pancreatic Cancer | not yet recruiting | N/A | 12 | Peking Union Medical College HospitalOTHER | 1 | Aug 11, 2025 | clinicaltrials |
| NCT07101900 | 68Ga-NYM096 PET/ CT for the Detection of Clear Cell Renal Cell Carcinoma in Presurgical Patients With Renal Masses | enrolling by invitation | Phase 2 | 100 | Peking Union Medical College HospitalOTHER | 1 | Aug 8, 2025 | clinicaltrials |
| NCT07106528 | Organoid-guided vs Topotecan Therapy in Relapsed Extensive-Stage Small Cell Lung Cancer | not yet recruiting | Phase 2 / Phase 3 | 128 | Peking Union Medical College HospitalOTHER | 0 | Aug 6, 2025 | clinicaltrials |
| NCT07108127 | Efficacy and Safety of Trastuzumab Biosimilars and Pertuzumab Biosimilars Combined With Chemotherapy for Neoadjuvant Treatment of Patients With Locally Advanced HER2-positive Rectal Cancer(NePHera) | recruiting | Phase 2 | 24 | Peking Union Medical College HospitalOTHER | 1 | Aug 6, 2025 | clinicaltrials |
| NCT06844110 | Application of 68GA-labeled CD73 Targeting Probe PET/CT Imaging in the Diagnosis of Malignant Tumor | recruiting | N/A | 50 | Peking Union Medical College HospitalOTHER | 1 | Aug 5, 2025 | clinicaltrials |
| NCT07023640 | Application of the CD73-Targeted Probe ⁶⁸Ga-DOTA-mPNE PET/CT Imaging in the Diagnosis of Malignant Tumors | recruiting | N/A | 50 | Peking Union Medical College HospitalOTHER | 1 | Aug 5, 2025 | clinicaltrials |
| NCT06027541 | Young Patients With Early Breast Cancer | active not recruiting | — | 1,000 | Peking Union Medical College HospitalOTHER | 1 | Aug 3, 2025 | clinicaltrials |
| NCT07101237 | An Exploratory Study on Developing an Integrated Approach Combining Multimodal Imaging and Multi-omics Characterization of Tumor Heterogeneity for Precision Diagnosis and Treatment Optimization in Liver Cancer. | recruiting | — | 308 | Peking Union Medical College HospitalOTHER | 1 | Aug 3, 2025 | clinicaltrials |
| NCT07079423 | Teclistamab in Newly Diagnosed Mayo Stage IIIB AL Amyloidosis | recruiting | Phase 2 | 35 | Peking Union Medical College HospitalOTHER | 1 | Jul 23, 2025 | clinicaltrials |
| NCT04560127 | Camrelizumab in Combination With Apatinib in Patients With Radioactive Iodine-refractory Differentiated Thyroid Cancer | active not recruiting | Phase 2 | 20 | Peking Union Medical College HospitalOTHER | 1 | Jul 10, 2025 | clinicaltrials |
| NCT06632860 | A Dual-targeting Tracer TATE-RGD for the Diagnosis of SSTR- and RGD- Positive Tumors | recruiting | Early Phase 1 | 40 | Peking Union Medical College HospitalOTHER | 1 | Jul 9, 2025 | clinicaltrials |
| NCT06957626 | Development and Validation of Microbiota and Metabolite-based Prediction Model for Recurrence of High-risk Colorectal Polyps After Polypectomy | recruiting | — | 150 | Peking Union Medical College HospitalOTHER | 1 | Jul 1, 2025 | clinicaltrials |
| NCT07029659 | A Study Evaluating the Diagnostic Performance of OCS in the Differential Diagnosis of Endometriosis vs. Endometriosis-Associated Ovarian Cancer | not yet recruiting | — | 336 | Peking Union Medical College HospitalOTHER | 1 | Jun 19, 2025 | clinicaltrials |
| NCT01354522 | TAC Versus TCX as Adjuvant Treatment for High-risk Her2-Negative Breast Cancer | completed | Phase 3 | 204 | Peking Union Medical College HospitalOTHER | 1 | Jun 15, 2025 | clinicaltrials |
| NCT07023068 | ⁶⁸Ga-DPA in the Lung Cancer Diagnosis | enrolling by invitation | Early Phase 1 | 40 | Peking Union Medical College HospitalOTHER | 1 | Jun 15, 2025 | clinicaltrials |
| NCT07012707 | Rationale and Trial Design of PFB-03 Study: Diagnostic Performance and Clinical Application of 18F-FAPI-PET/CT for Detecting Axillary Lymph Node Metastasis in Breast Cancer Patients After Neoadjuvant Therapy | not yet recruiting | — | 172 | Peking Union Medical College HospitalOTHER | 0 | Jun 10, 2025 | clinicaltrials |
| NCT05822817 | Comparison of Postoperative Recovery of Sevoflurane and Propofol After Transsphenoidal Surgery | completed | Phase 4 | 252 | Peking Union Medical College HospitalOTHER | 1 | Jun 8, 2025 | clinicaltrials |
| NCT05994300 | Moderately Hypofractionated Adaptive Radiotherapy for Cervical Cancer | active not recruiting | N/A | 30 | Peking Union Medical College HospitalOTHER | 1 | Jun 8, 2025 | clinicaltrials |
| NCT04834505 | To Differentiate Focal Autoimmune Pancreatitis From Pancreatic Cancer by Endoscopic Ultrasound | completed | — | 286 | Peking Union Medical College HospitalOTHER | 1 | May 31, 2025 | clinicaltrials |
| NCT06935162 | Teclistamab in Previously Treated AL Amyloidosis | recruiting | Phase 2 | 30 | Peking Union Medical College HospitalOTHER | 1 | May 25, 2025 | clinicaltrials |
| NCT04655677 | A Study of C-CAR039 Treatment in Subjects With r/r NHL SubjectsNon-Hodgkin's Lymphoma | completed | Phase 1 | 10 | Peking Union Medical College HospitalOTHER | 1 | May 23, 2025 | clinicaltrials |
| NCT06941766 | Iparomlimab and Tuvonralimab (QL1706) for Intermediate Trophoblastic Tumors | recruiting | Phase 1 / Phase 2 | 20 | Peking Union Medical College HospitalOTHER | 1 | Apr 30, 2025 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials